Browse by Phase
Phase 2 Clinical Trials
Phase 2 trials study whether a drug works in people with a specific disease or condition. These studies enroll 100–300 participants and also continue to evaluate safety.
Total Trials
1,071
Recruiting Now
1,071
Top Conditions in Phase 2
NCT05675930 Phase 2
Recruiting
A Study of Photobiomodulation (PBM) Therapy in People With Oral Graft-Versus-Hos...
Condition
Graft-Versus-Host Disease
Enrollment
44 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT06118567 Phase 2
Recruiting
Effect of Nitrous Oxide on Aggression.
Condition
Intermittent Explosive Disorder
Enrollment
50 pts
Location
United States
Sponsor
Ohio State University
NCT06074692 Phase 2
Recruiting
PARP Inhibition, Stereotactic Body Radiotherapy and Immunotherapy for Metastatic...
Condition
Sarcoma
Enrollment
86 pts
Location
China
Sponsor
Ruijin Hospital
NCT03128879 Phase 2
Recruiting
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
Condition
Chronic Lymphocytic Leukemia
Enrollment
90 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT06572462 Phase 2
Recruiting
ATG Individualized Dosing Model in URD-PBSCT.
Condition
Cytomegalovirus Infections
Enrollment
30 pts
Location
China
Sponsor
Chinese PLA General Hospital
NCT05657873 Phase 2
Recruiting
A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer ...
Condition
Non Small Cell Lung Cancer
Enrollment
68 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT05894083 Phase 2
Recruiting
A Phase II Study for p16+ Oropharyngeal Cancer PerSonalized De-escalation Treatm...
Condition
Oropharyngeal Cancer
Enrollment
150 pts
Location
United States
Sponsor
University of Michigan Rogel C
NCT04866654 Phase 2
Recruiting
Radiation Free Chemotherapy for Early Hodgkin Lymphoma
Condition
Hodgkin Lymphoma
Enrollment
160 pts
Location
Italy, Poland, Spain
Sponsor
Medical University of Gdansk
NCT06689254 Phase 2
Recruiting
REVERSE: Improving Treatment-resistant Post Traumatic Stress Disorder (PTSD) wit...
Condition
Treatment-resistant PTSD
Enrollment
60 pts
Location
Netherlands
Sponsor
Christiaan Vinkers
NCT06721494 Phase 2
Recruiting
A Single-Dose Study to Evaluate Safety and Efficacy of CS-1103 in Participants R...
Condition
Methamphetamine Intoxication
Enrollment
40 pts
Location
United States
Sponsor
Clear Scientific, Inc.
NCT06640166 Phase 2
Recruiting
Encorafenib + Cetuximab Beyond Progression in Combination With FOLFIRI in Patien...
Condition
Colorectal Carcinoma
Enrollment
25 pts
Location
Italy
Sponsor
Fondazione Policlinico Univers
NCT05849129 Phase 2
Recruiting
Adjunctive Intravenous Ascorbic Acid for Advanced Non-Small Cell Lung Cancer
Condition
Lung Cancer
Enrollment
90 pts
Location
Canada
Sponsor
The Canadian College of Naturo
NCT07277439 Phase 2
Recruiting
Phase II Trial of Neoadjuvant Thymalfasin, PD-1 Inhibitor, and Chemoradiotherapy...
Condition
Gastric Cancer
Enrollment
48 pts
Location
China
Sponsor
The First Affiliated Hospital
NCT07117630 Phase 2
Recruiting
An Open-Label, Bayesian Adaptive Phase II Clinical Study in HR+/HER2- Advanced B...
Condition
Breast Cancer
Enrollment
20 pts
Location
China
Sponsor
Fudan University
NCT07175428 Phase 2
Recruiting
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Antic...
Condition
Atrial Fibrillation (AF)
Enrollment
1,200 pts
Location
United States, Canada
Sponsor
Regeneron Pharmaceuticals
NCT04055428 Phase 2
Recruiting
NAUTICAL: Effect of Natriuretic Peptide Augmentation on Cardiometabolic Health i...
Condition
Diabetes Mellitus
Enrollment
200 pts
Location
United States
Sponsor
University of Alabama at Birmi
NCT05332067 Phase 2
Recruiting
Omalizumab Before Onset of Exacerbations
Condition
Asthma in Children
Enrollment
300 pts
Location
United States
Sponsor
Children's National Research I
NCT05733767 Phase 2
Recruiting
Smoking Cessation Pharmacotherapy-Nurse Practitioner Led Tobacco Treatment Team ...
Condition
Cardiopulmonary Disease
Enrollment
424 pts
Location
United States
Sponsor
Baystate Medical Center
NCT06667167 Phase 2
Recruiting
First Line Therapy for Extensive SCLC Patients, Treated with Chemo+Keytruda Foll...
Condition
NSCLC (non-small Cell Lung Cancer)
Enrollment
21 pts
Location
Israel
Sponsor
Nir Peled
NCT02800486 Phase 2
Recruiting
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Rei...
Condition
Glioblastoma
Enrollment
37 pts
Location
United States
Sponsor
Northwell Health
NCT06073886 Phase 2
Recruiting
Personalized Brain Stimulation to Treat Chronic Concussive Symptoms
Condition
Post-Concussion Syndrome
Enrollment
75 pts
Location
United States
Sponsor
University of California, Los
NCT06672822 Phase 2
Recruiting
Intralesional Injection of STS in Treatment of Calcinosis
Condition
Systemic Sclerosis (SSc)
Enrollment
20 pts
Location
United States
Sponsor
Robyn T. Domsic, MD, MPH
NCT02029001 Phase 2
Recruiting
Adapting Treatment to the Tumor Molecular Alterations for Patients With Advanced...
Condition
Malignant Solid Neoplasms
Enrollment
900 pts
Location
France
Sponsor
Centre Leon Berard
NCT04559230 Phase 2
Recruiting
Sacituzumab Govitecan in Recurrent Glioblastoma
Condition
Recurrent Glioblastoma
Enrollment
32 pts
Location
United States
Sponsor
The University of Texas Health
NCT06019130 Phase 2
Recruiting
Nivolumab in Children and Adults With Nasopharyngeal Carcinoma
Condition
Nasopharyngeal Carcinoma
Enrollment
57 pts
Location
Germany
Sponsor
German Society for Pediatric O